Impact and course of albuminuria in acute heart failure according to left or right sided heart failure phenotype

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Mr Jonathan Deniz Rosario

University Hospital Dr Negrin, Las Palmas de Gran Canaria (Spain)

7 More presentations in this session

Presentation thumbnail

Levosimendan therapy and mortality predictors in end-stage heart failure patients beyond advanced therapeutic options

Doctor S. Jimenez-Marrero (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

Prognostic impact of urine output after catecholamine administration in cardiogenic shock due to acute decompensated heart failure

Doctor S. Kawanami (Sakai, JP)

Abstract Slides Video

Presentation thumbnail

Impact of in-hospital initiation of angiotensin receptor-neprilysin inhibition on left ventricular reverse remodeling in acute heart failure: an insight from PREMIER trial

Assistant Professor T. Takahashi (Tokushima, JP)

Abstract Slides Video

Presentation thumbnail

Prognostic value of energetic hemodynamics in acute heart failure: beyond conventional measures

Doctor H. Chang (Taipei, TW)

Abstract Slides Video

Presentation thumbnail

Guideline directed medical treatment and comorbidity burden among patients admitted with acute HF decompensation: insights from the HECMOS 2.0

Doctor I. Leontsinis (Athens, GR)

Abstract Slides Video

Access the full session

Session thumbnail

In-hospital care of acute heart failure

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Albuminuria and acute heart failure. Prognostic implications and short-term mortality.

Congress Session

New tools to detect and treat acute heart failure

Congress Session

Mechanisms of heart failure: emerging evidence

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources